Welcome to Francis Academic Press

Frontiers in Medical Science Research, 2022, 4(7); doi: 10.25236/FMSR.2022.040706.

Preparation of peG-DOX nanoparticles as nano drug carrier and treatment methods to achieve the best effect

Author(s)

Zheming Tang1, Shuo Wu2, Yinuo Wang3, Weiting Shen4

Corresponding Author:
Shuo Wu
Affiliation(s)

1Christ School, NY, USA

2China Jiliang University, Hangzhou, Zhejiang, China

3Northwestern Polytechnical University, Xi’an, Shaanxi, China

4Henan Polytechnic University, Jiaozuo, Henan, China

Abstract

Among anticancer drugs, the research and development and preparation of nano drugs have always been the focus of current researchers, looking for appropriate molecular carriers that can make drugs play a better role. In this paper, PEG-DOX polymer was synthesized by using Poly(ethylene glycol) methyl ether (PEG-OH), 4-carboxybenzaldehyde, 4-(dimethyl-amino)-pyridine (DMAP), 1-(3-dimethylamino propyl)-3-ethyl carbodiimide hydrochloride (EDCI), triethylamine (TEA), hydrochloric acid, sodium sulfate, sodium bicarbonate, etc., through reasonable design and assembly, The stability, release behavior and antitumor activity of the drug were determined experimentally, to explore the best preparation scheme for the best effect of the drug.

Keywords

peG-DOX nanoparticles, Nano drugs, Anticancer drugs

Cite This Paper

Zheming Tang, Shuo Wu, Yinuo Wang, Weiting Shen. Preparation of peG-DOX nanoparticles as nano drug carrier and treatment methods to achieve the best effect. Frontiers in Medical Science Research (2022) Vol. 4, Issue 7: 38-43. https://doi.org/10.25236/FMSR.2022.040706.

References

[1] Ding, Y., Zhou, Y. Y., Chen, H., Geng, D. D., Wu, D. Y., Hong, J. & Zhang, C. (2013). The performance of thiol-terminated PEG-paclitaxel-conjugated gold nanoparticles. Biomaterials, 34(38), 10217-10227.

[2] Lee, C.; Lo, S.T.; Lim, J.; da Costa, V.C.; Ramezani, S.; Oz, O.K.; Pavan, G.M.; Annunziata, O.; Sun, X.; Simanek, E.E. (2013) Design, synthesis and biological assessment of a triazine dendrimer with approximately 16 paclitaxel groups and 8 PEG groups. Mol. Pharm. 10, 4452–4461. 

[3] Sun, Q., Radosz, M., & Shen, Y. (2012). Challenges in design of translational nanocarriers. Journal of controlled release, 164(2), 156-169.